title: Molecular analysis of mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexa.
abstract: Lymphomas of mucosa-associated lymphoid tissue (MALT) are a distinct subgroup of extranodal B-cell non-Hodgkin's lymphomas. Most studies have failed to demonstrate the clonal rearrangement of BCL-1, BCL-2 or c-MYC genes for MALT lymphomas. Further, alteration of the p53 gene is rarely demonstrated in low-grade MALT lymphomas, but can be detected in high-grade disease. Lymphomas of the ocular adnexa represent approximately eight percent of all extranodal lymphomas, most of which are MALT lymphomas, but few studies had explored the alterations of BCL-1, BCL-2, c-MYC and p53 genes specifically for ocular MALT lymphomas. We investigated the changes to BCL-1, BCL-2, c-MYC and p53 genes in these lymphomas for Taiwanese patients. Clonal rearrangement for immunoglobulin heavy-chain (IgH), BCL-1, BCL-2, c-MYC and p53 genes was examined for 16 cases of ocular MALT lymphoma. Restriction-length polymorphism and polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) of the DNA, corresponding to exons 5 through 9, followed by DNA sequencing, were utilized to analyze the possible mutations of the p53 gene for these tumors. Thirteen of the cases revealed rearranged IgH genes using Southern blotting or PCR. No rearrangement of BCL-1, BCL-2, c-MYC or p53 genes was discovered, with point mutation of the p53 gene in one case. As for other types of MALT lymphomas, BCL-1, BCL-2 and c-MYC genes are not implicated in the pathogenesis of the ocular sub-group. Although alteration of the p53 gene is rare for low-grade ocular MALT lymphoma, its role in disease progression merits further research.
authors.affiliation: Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, Taipei, Taiwan, R.O.C.
authors.forename: P M
authors.initials: PM
authors.lastname: Chen
authors.forename: T J
authors.initials: TJ
authors.lastname: Chiou
authors.forename: I T
authors.initials: IT
authors.lastname: Yu
authors.forename: F S
authors.initials: FS
authors.lastname: Fan
authors.forename: C J
authors.initials: CJ
authors.lastname: Chu
authors.forename: S C
authors.initials: SC
authors.lastname: Kao
authors.forename: W S
authors.initials: WS
authors.lastname: Wang
authors.forename: J H
authors.initials: JH
authors.lastname: Liu
authors.forename: W M
authors.initials: WM
authors.lastname: Hsu
authors.forename: M H
authors.initials: MH
authors.lastname: Yang
authors.forename: T C
authors.initials: TC
authors.lastname: Chao
authors.forename: C J
authors.initials: CJ
authors.lastname: Tai
authors.forename: L T
authors.initials: LT
authors.lastname: Hsiao
authors.forename: J T
authors.initials: JT
authors.lastname: Lin
authors.forename: C C
authors.initials: CC
authors.lastname: Yen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004252:DNA Mutational Analysis; D005134:Eye Neoplasms / Q000209:etiology / Q000235:genetics*; D005260:Female; D015321:Gene Rearrangement; D005803:Genes, Immunoglobulin; D019940:Genes, bcl-1; D019254:Genes, bcl-2; D016259:Genes, myc; D016158:Genes, p53; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000209:etiology / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D013624:Taiwan